Discovery
Civ-Pro
Case Summary |
|
4789 REVIEW DENIED The manufacturer of a brand-name prescription drug owes users of the generic form of the drug a duty to provide adequate warnings and may be liable to them for negligent misrepresentations made in the warnings it provides to prescribers of the brand name version.CitationCONTE v WYETH (Brand-name Drug) 168 CA4 89 [See: CivC 1710; B&PC 4073; Carlin v Superior Court 13 C4 1104, T/AT 10/96; Rowland v Christian 69 C2 108; Mckenney v Purepac 167 CA4 72, T/AT 11/08] |
|
|
|||||
|
|||||
Finz Case Law Summaries (Finz Advance Tapes)
|
|||||
Copyright by Pincus Legal Education, Inc. ©1992 - 2022
|
|||||